Welcome to InOncology.com

Discover how Boehringer Ingelheim is committed to taking cancer on. Our goal is to transform the lives of patients by developing innovative, first-in-class treatments for lung and gastrointestinal cancers.

Pipeline compounds shown here are under pre-clinical and/or clinical investigation, and have not been approved. Their safety and efficacy have not been established.

RESOURCES

Pipeline compounds shown here are under pre-clinical and/or clinical investigation, and have not been approved. Their safety and efficacy have not been established.

 

© 2021 Boehringer Ingelheim Pharmaceuticals Inc. All rights reserved.

 

SC-US-65618

 

Page last updated: February 2021